Sergio Poli De Frias, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Idiopathic Pulmonary Fibrosis | 9 | 2022 | 499 | 0.910 |
Why?
|
Lung | 15 | 2022 | 9989 | 0.490 |
Why?
|
Organoids | 1 | 2021 | 729 | 0.480 |
Why?
|
Single-Cell Analysis | 7 | 2022 | 2368 | 0.470 |
Why?
|
Lung Diseases, Interstitial | 4 | 2022 | 907 | 0.410 |
Why?
|
Pulmonary Fibrosis | 3 | 2021 | 507 | 0.390 |
Why?
|
Retina | 1 | 2021 | 2635 | 0.340 |
Why?
|
Lymphangioleiomyomatosis | 2 | 2021 | 203 | 0.310 |
Why?
|
Virus Internalization | 2 | 2021 | 494 | 0.290 |
Why?
|
Syndecan-2 | 2 | 2021 | 23 | 0.220 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2022 | 3223 | 0.200 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2021 | 18 | 0.190 |
Why?
|
Emphysema | 1 | 2022 | 240 | 0.170 |
Why?
|
Hexosaminidases | 1 | 2019 | 45 | 0.170 |
Why?
|
Airway Resistance | 1 | 2020 | 401 | 0.170 |
Why?
|
Smad7 Protein | 1 | 2019 | 40 | 0.170 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2021 | 203 | 0.160 |
Why?
|
Endostatins | 1 | 2019 | 168 | 0.160 |
Why?
|
Fibroblasts | 4 | 2021 | 4091 | 0.160 |
Why?
|
Retinal Pigment Epithelium | 1 | 2021 | 301 | 0.150 |
Why?
|
Receptor, Insulin | 1 | 2021 | 836 | 0.140 |
Why?
|
Arthritis, Rheumatoid | 2 | 2022 | 3763 | 0.140 |
Why?
|
Immunoglobulin A | 1 | 2019 | 978 | 0.130 |
Why?
|
Sequence Analysis, RNA | 2 | 2021 | 2003 | 0.130 |
Why?
|
Retinal Ganglion Cells | 1 | 2021 | 805 | 0.120 |
Why?
|
Cryopreservation | 1 | 2020 | 720 | 0.120 |
Why?
|
Transcriptional Activation | 1 | 2020 | 1755 | 0.120 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 776 | 0.120 |
Why?
|
Mammals | 1 | 2019 | 1129 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1180 | 0.110 |
Why?
|
Endothelial Cells | 3 | 2021 | 3537 | 0.110 |
Why?
|
Respiratory Tract Infections | 1 | 2021 | 1001 | 0.110 |
Why?
|
Cell Communication | 1 | 2021 | 1642 | 0.110 |
Why?
|
Pulmonary Emphysema | 1 | 2019 | 688 | 0.110 |
Why?
|
Gene Expression Profiling | 4 | 2022 | 9388 | 0.110 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1447 | 0.100 |
Why?
|
Cell Lineage | 1 | 2021 | 2525 | 0.100 |
Why?
|
Collagen | 1 | 2020 | 2635 | 0.100 |
Why?
|
Transforming Growth Factor beta | 1 | 2019 | 1956 | 0.090 |
Why?
|
Cystic Fibrosis | 1 | 2020 | 1274 | 0.090 |
Why?
|
Lung Diseases | 1 | 2021 | 1915 | 0.090 |
Why?
|
Autoantibodies | 1 | 2019 | 2119 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2138 | 0.090 |
Why?
|
Bleomycin | 2 | 2021 | 496 | 0.090 |
Why?
|
RNA | 1 | 2020 | 2721 | 0.090 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1570 | 0.080 |
Why?
|
Family | 1 | 2020 | 3189 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2874 | 0.080 |
Why?
|
Pulmonary Alveoli | 2 | 2022 | 653 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3525 | 0.070 |
Why?
|
Genetic Testing | 1 | 2021 | 3530 | 0.070 |
Why?
|
Organ Specificity | 2 | 2021 | 1955 | 0.070 |
Why?
|
Mass Screening | 1 | 2021 | 5422 | 0.060 |
Why?
|
Inflammation | 2 | 2021 | 10757 | 0.060 |
Why?
|
Humans | 24 | 2022 | 760261 | 0.060 |
Why?
|
Gene Silencing | 2 | 2019 | 1511 | 0.050 |
Why?
|
Ribotyping | 1 | 2021 | 35 | 0.050 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2021 | 24 | 0.050 |
Why?
|
Cathepsin L | 1 | 2021 | 68 | 0.050 |
Why?
|
Lung Diseases, Fungal | 1 | 2021 | 125 | 0.050 |
Why?
|
Signal Transduction | 5 | 2022 | 23363 | 0.040 |
Why?
|
Syntenins | 1 | 2019 | 8 | 0.040 |
Why?
|
Semaphorins | 1 | 2019 | 97 | 0.040 |
Why?
|
Activins | 1 | 2020 | 210 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3618 | 0.040 |
Why?
|
Transcription Factor RelA | 1 | 2019 | 251 | 0.040 |
Why?
|
Capillaries | 1 | 2021 | 745 | 0.040 |
Why?
|
Extracellular Space | 1 | 2019 | 565 | 0.040 |
Why?
|
Respiratory System | 1 | 2021 | 554 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2021 | 675 | 0.040 |
Why?
|
Respiration Disorders | 1 | 2020 | 368 | 0.030 |
Why?
|
Animals | 7 | 2022 | 167940 | 0.030 |
Why?
|
Microcirculation | 1 | 2021 | 1279 | 0.030 |
Why?
|
Demography | 1 | 2021 | 1650 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2019 | 633 | 0.030 |
Why?
|
Spirometry | 1 | 2019 | 924 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2020 | 829 | 0.030 |
Why?
|
Genes | 1 | 2019 | 1845 | 0.030 |
Why?
|
Aged | 7 | 2021 | 168995 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2021 | 1021 | 0.030 |
Why?
|
Species Specificity | 1 | 2019 | 2413 | 0.030 |
Why?
|
Pulmonary Veins | 1 | 2021 | 745 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2020 | 1684 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2019 | 1531 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2022 | 2698 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13249 | 0.030 |
Why?
|
Fibrosis | 1 | 2021 | 2042 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2020 | 2056 | 0.030 |
Why?
|
Cell Separation | 1 | 2020 | 1720 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1791 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2021 | 1739 | 0.030 |
Why?
|
Mice | 4 | 2022 | 81216 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2627 | 0.030 |
Why?
|
Middle Aged | 7 | 2021 | 220175 | 0.030 |
Why?
|
Virus Replication | 1 | 2021 | 2431 | 0.030 |
Why?
|
Autophagy | 1 | 2021 | 1336 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2022 | 1740 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4577 | 0.030 |
Why?
|
Female | 9 | 2022 | 391011 | 0.030 |
Why?
|
Phenotype | 2 | 2021 | 16543 | 0.030 |
Why?
|
NF-kappa B | 1 | 2021 | 2486 | 0.030 |
Why?
|
Ligands | 1 | 2019 | 3277 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2449 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2022 | 22025 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2021 | 1919 | 0.030 |
Why?
|
Male | 8 | 2022 | 359413 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2058 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2866 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3618 | 0.020 |
Why?
|
Tuberous Sclerosis | 1 | 2019 | 1030 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1843 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2019 | 2825 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2019 | 2909 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4127 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 3443 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5796 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2022 | 3665 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2020 | 5873 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9531 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2021 | 3046 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3504 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5876 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3810 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5120 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3483 | 0.020 |
Why?
|
Homeostasis | 1 | 2019 | 3305 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5784 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9283 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20484 | 0.020 |
Why?
|
Cohort Studies | 2 | 2019 | 41317 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2022 | 18968 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14396 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15626 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58947 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12156 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11064 | 0.020 |
Why?
|
Adult | 4 | 2021 | 219847 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13505 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13311 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10434 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8498 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15687 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8449 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11480 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18134 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11902 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39254 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40133 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54263 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 80301 | 0.010 |
Why?
|